ДИАГНОСТИКА ЭРАДИКАЦИИ ПО УРОВНЮ АНТИТЕЛ IG G К

, 2009,
8,
1
IG G
HELICOBACTER PYLORI
.
«
»
Helicobacter pylori
( . pylori)
,
,
. pylori
,
,
MALT-
[10].
.
(
).
,
,
(
).
. pylori,
,
,
.
,
.
.
,
,
,
,
[7, 12, 13].
. pylori
,
,
:
,
,
[14].
H. pylori
[10].
. pylori
.
14
13
,
. pylori.
. pylori. [13, 14].
,
, 2009,
8,
1
.
,
,
.
H. pylori.
IgG
H. pylori
[4, 7, 11, 14].
H. pylori
,
,
.
IgG
3-6
.
42
[9].
100%
IgG
H. pylori
.
IgG H. pylori.
89
(67
22
)
H. pylori.
42, 28±9,83
IgG
.
H. pylori
,
«GastroPanel» (Biohit Pic,
).
.
10
,
15
2000 G.
20° .
IgG
H.pylori
H. pylori
.
,
.
.
H.pylori,
,
96IgG
.
.
IgG
96-
,
H.pylori,
.
2
H.pylor,
, 2009,
8,
1
,
.
IgG
H.pylori
.
0,1
,
.
38 EIU
.
.
«ProntoDry» (MIC,
-
)
,
.
(
)
2
2 –
.
,
=1,0
,
=2,5).
.
1,
,
,
,
,
,
(
IgG
) [3].
H. pylori
.
UMann-Whitney
Statistica 6,0 (StatSoft Inc., Okla., USA).
p<0,05.
:
,
[1].
,
H. pylori.
,
–
,
,
H. pylori
,
3
, 2009,
8,
1
.
,
,
.
( >0,1).
IgG
H. pylori
H. pylori.
,
(
.).
Helicobacter pylori
IgG
H. pylori
M±
94,30±32,43
p
n=30
84,78±38,11
p
65,00±15,45
72,82±32,55
10,60±22,95
0,361
M±
89,24±34,80
p
n=41
32,22±18,72
<0,001
M±
n=18
%
<0,001*
52,90±28,34
39,23±28,68
<0,001
<0,001*
: *–
.
,
H. pylori
.
,
3
.
H. pylori
,
,
.
IgG
,
H. pylori.
,
.
.
,
,
,
40%,
5%
H. pylori
H. pylori.
,
H. pylori
2%.
,
4
, 2009,
8,
1
1, 2, 3
52%
U/
61%
4
,
23%, 41%,
.
.
50
,
H. pylori-
H. pylori
50 U/
4
,
2-2,5%
H. pylori
50 U/
.
,
[10].
(
H. pylori
cut-off)
50%
IgG
.
,
IgG
H. pylori,
:
H. pylori
.
17
,
–
1,
–
– 25.
,
IgG
83,3%
– 94,4%,
– 96,2%,
– 77,3%.
H. pylori
87,5%,
IgG
–
H. pylori.
38
(7,3%) –
.
15
IgG
5,
H. pylori
50%
(36,6%), 23
,
(92,7%),
(56,1%)
50%.
IgG
H. pylori
.
,
318
,
,
F. Lerang
IgG
3-6
H. pylori
40%
H. pylori
[4].
93%,
247
50%
100%.
IgG
3-6
H. pylori.
44%,
– 87%
[6].
,
,
4
5
20%
, 2009,
8,
1
H. pylori,
,
20% –
.
90% [2].
,
,
43
,
12-21
IgG
20%,
93% [5].
,
3-12
IgG
,
,
20%
H. pylori.
80%
,
[4, 11, 14].
H. pylori –
IgG H. pylori
60%
1
.
90%
– 87%.
[10].
H. pylori,
,
,
,
.
,
. pylori,
.
1.
IgG
H. pylori
50%
.
2.
IgG
87,5%,
– 83,3%
– 94,4%,
– 96,2%,
1.
H. pylori
– 77,3%.
, . .
/ . .
.–
, 1988. – 256 .
2.
, . .
/
. .
,
. .
. –
.:
, 2003. – 412 .
3.
, . .
Helicobacter pylori / . .
, . .
//
6
. – 2005. –
1. – . 19-23.
.:
, 2009,
4.
8,
1
Accuracy of IgG serology and other tests in confirming Helicobacter pylori eradication /
F. Lerang [et al.] // Scand. J. Gastroenterol. – 1998. – Vol. 33. – P. 710-715.
5.
Cutler, A. F. Long term follow- up of Helicobacter pylori serology after successful
eradication / A. F. Cutler, V. M. Prasad // Am. J. Gastroenterol. – 1996. – Vol. 91. – P. 85–88.
6.
Effect of antimicrobial therapy on the specific serological response to Helicobacter
pylori infection / Y. Glupczynski [et al]. // Eur. J. Clin. Microbiol. Infect. Dis. – 1992. – Vol.
11. – P. 583-588.
7.
Go, M. F. Review article: natural history and epidemiology of Helicobacter pylori
infection / M. F. Go // Aliment. Pharmacol. Ther. – 2002. – Vol. 16. – Suppl. 1. – P. 3-15.
8.
Helicobacter pylori infection and the development of gastric cancer / N. Uemura [et al.]
// N. Engl. J. Med. – 2001. – Vol. 345. – P. 784-789.
9.Herbrink, P Serological methods for diagnosis of Helicobacter pylori infection and
monitoring eradication therapy / P. Herbrink, L. J. van Doorn // Eur. J. Clin. Microbiol. Infec.
Dis. – 2000. –Vol. 19. – P. 164-173.
10. Host serological response to Helicobacter pylori after successful eradication: long-term
follow-up in patients with cured and persistent infection / J. Tanaka [et al.] // Aliment.
Pharmacol. Ther. – Vol. 24. – Suppl. 4. – P. 239-248.
11. Longterm follow-up and serologic assessment after triple therapy with omeprazole or
lansoprazole of Helicobacter-associated duodenal ulcer / L. Fanti [et al.] // J. Clin.
Gastroenterol. – 2001. – Vol. 32. – P. 45-48.
12. Review article: Helicobacter pylori infection from pathogenesis to treatment – a critical
eappraisal / D. Vaira [et al.] // Aliment. Pharmacol. Ther. – 2002. – Vol.16. – Suppl. 4. –
P.105–113.
13. The Efficacy of Laboratory Diagnosis of Helicobacter pylori Infections in Gastric
Biopsy Specimens in Related to Bacterial Density and vacA, cagA, and iceA genotypes /
L. J. van Doorn [et al.] // J. Clin. Microbiol. – 2000. – Vol.38, N.1. – P. 13-17.
14. Usefulness of serological IgG antibody determination for confirming eradication of
Helicobacter pylori infection / P. Marchildon [et al.] // Am. J. Gastroenterol. – 1999. – Vol. 94.
– P. 2105-2108.
7